EarningsQ2 2026 Earnings Report

Innovent Biologics (1801N) Q2 2026 Earnings Report

1 Followers

MX:1801N Q2 2026 EPS Results

Actual EPS$1.88

Consensus EPS$1.26

Beat/MissBeat by +$0.62

One Year Ago EPS$1.37

Actual Revenue$22.52B

Expected Revenue$23.85B

Beat/MissMissed by -$1.34B

YoY Revenue Growth+53.63%

QuarterQ2 2026

Date08/25/2026

TimeBefore Open

Conference CallTuesday, August 25, 2026

MX:1801N Upcoming Earnings

Innovent Biologics's next earnings date is estimated for March 31, 2027, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Mar 31, 2027	2026 (Q4)	3.05 / -	-0.027	―
Aug 25, 2026	2026 (Q2)	1.26 / 1.88	1.366	37.25% (+0.51)
Mar 26, 2026	2025 (Q4)	0.32 / -0.03	0.482	-105.56% (-0.51)
Aug 27, 2025	2025 (Q2)	0.48 / 1.37	-0.643	312.50% (+2.01)
Mar 26, 2025	2024 (Q4)	-0.62 / 0.48	-1.522	131.69% (+2.00)
Aug 28, 2024	2024 (Q2)	-0.67 / -0.64	-0.241	-166.67% (-0.40)
Mar 20, 2024	2023 (Q4)	-1.88 / -1.52	-2.251	32.38% (+0.73)
Aug 23, 2023	2023 (Q2)	-1.80 / -0.24	-1.742	86.15% (+1.50)
Mar 31, 2023	2022 (Q4)	-1.77 / -2.25	-3.617	37.78% (+1.37)
Aug 25, 2022	2022 (Q2)	-18.34 / -1.74	-2.17	19.75% (+0.43)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed